IINN Inspira Technologies
Price Chart
Executive Summary
Inspira Technologies reported minimal revenue of $289,000 in 2025 with a net loss of $13.22 million, reflecting ongoing commercialization challenges. Despite the weak financials, the company secured $49.5 million in binding purchase orders expected to drive revenue in 2026 and raised $4.75 million in a follow-on offering, improving liquidity and Nasdaq compliance. Clinical deployments are expanding, and the company is advancing its HYLA blood sensor platform.
Key Financial Metrics
Actionable Insight
Watch for revenue recognition from the $49.5M in purchase orders in 2026 and any updates on strategic alternatives. The stock may react positively if procurement conversions accelerate, but remains high-risk due to minimal current revenue and history of losses.
Key Facts
- Reported $289,000 in revenue for 2025, up from $0 in 2024
- Net loss widened to $13.22 million in 2025 from $11.05 million in 2024
- Secured $49.5 million in binding purchase orders, with revenue expected in 2026
- Raised $4.75 million in a registered direct offering post-year-end
- Cash and equivalents dropped to $3.16 million from $5.78 million in 2024
- Appointed new VP of Global Sales and expanded clinical use at U.S. medical centers
- Terminated non-binding term sheet with Bio-View Ltd., evaluating other strategic options
Financial Impact
Revenue of $289,000 is negligible; $49.5M in future orders represents significant potential upside in 2026
Risk Factors
- Minimal current revenue and sustained losses raise sustainability concerns
- Revenue from $49.5M in orders is deferred and subject to procurement delays
- High share-based compensation and executive turnover may signal governance risks
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3263441 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 18, 2026
5d ago
|
Press Release
| $0.3996 awaiting T+5 | awaiting T+5 | — | $0.7270 (+81.93%) |
|
May 11, 2026
12d ago
|
Press Release
| $0.4070 $0.3720 | ▼ −8.60% | ▼ −8.51% | $0.7270 (+78.62%) |
|
May 1, 2026
22d ago
|
Press Release
| $0.4680 $0.4500 | ▼ −3.85% | ▼ −6.19% | $0.7270 (+55.34%) |
|
Apr 16, 2026
5w ago
|
Press Release
| $0.4950 $0.5400 | ▲ +9.09% | ▲ +8.11% | $0.7270 (+46.87%) |
|
Apr 14, 2026
5w ago
|
Press Release
| $0.4750 $0.5800 | ▲ +22.11% | ▲ +20.71% | $0.7270 (+53.05%) |
|
Apr 13, 2026
5w ago
|
Press Release
| $0.5080 $0.5870 | ▲ +15.55% | ▲ +12.26% | $0.7270 (+43.11%) |
|
Apr 6, 2026
6w ago
|
Press Release
| $0.4110 $0.5080 | ▲ +23.60% | ▲ +19.47% | $0.7270 (+76.89%) |
|
Apr 6, 2026
6w ago
|
Press Release
| $0.4110 $0.5080 | ▲ +23.60% | ▲ +19.47% | $0.7270 (+76.89%) |
|
Mar 31, 2026
7w ago
|
Press Release
| $0.4470 $0.4260 | ▼ −4.70% | ▼ −8.64% | $0.7270 (+62.64%) |
|
Mar 26, 2026
8w ago
|
Press Release
| $0.3930 $0.4110 | ▲ +4.58% | ▲ +0.72% | $0.7270 (+84.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access